This article from the New York Times says an awful lot about why we are raising money, particularly this paragraph:
She has come to think that survival may depend on money and access, and, she said, on “your own drive and motivation — are you Type A? — your education and your ability to sort through the medical world and the insurance world terminology.”
It's clear to me that not just in the States, but here too, not everybody is equal in the cancer world, not all treatments are equal, and not all access is equal. The point about building a trials unit, such as the one which our money is building, is to make sure that as many cancer patients as possible are seen in the same building, with access to the same top pool of doctors, and to all the possible trials. Also, there is a lot to be said for sitting in a waiting room with other patients who are having the same treatments, and finding out, firstly, that you are all getting the same, and how others are dealing with and reacting to the drugs.